• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Sitagliptin (as HCl monohydrate)
    2 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Sitamet-Avenir 50/1000 mg
    BioAvenir Ltd.
    RX
    not in the basket chart
    Multiple ingredients
    Sitamet-Avenir 50/1000 mg

    Biguanide, DPP-4 Inhibitor. Sitagliptin (as HCl monohydrate) 50 mg, Metformin Hydrochloride 1000 mg.
    FC Tabs.: 28/30/56/60/90. Dosage should be adj. indiv.
    As an adjunct to diet and exercise to improve glyc. ctrol. in adlt. with type 2 diab. mell. Important limit. of use: should not be used in type 1 diab. or for diab. ketoacid., as it would not be effec. Has not been studied in pts. with a hist. of pancreatitis. It is unknown whether they are at incr. risk for the develop. of pancreat. while using this drug
    C/I: Sev. renal impairm. (eGFR below 30 mL/min/1.73 m2)-
    Diab. ketoacid.- Type 1 diab.- Hist. of serious hypersens. react. to this drug, sitagliptin, or metformin, such as anaphylaxis or angioedema.

    Sitamet-Avenir 50/850 mg
    BioAvenir Ltd.
    RX
    not in the basket chart
    Multiple ingredients
    Sitamet-Avenir 50/850 mg

    Biguanide, DPP-4 Inhibitor. Sitagliptin (as HCl monohydrate) 50 mg, Metformin Hydrochloride 850 mg.
    FC Tabs.:14/28/30/90. Dosage should be adj. indiv.
    As an adjunct to diet and exercise to improve glyc. ctrol. in adlt. with type 2 diab. mell. Important limit. of use: should not be used in type 1 diab. or for diab. ketoacid., as it would not be effec. Has not been studied in pts. with a hist. of pancreatitis. It is unknown whether they are at incr. risk for the develop. of pancreat. while using this drug
    C/I: Sev. renal impairm. (eGFR below 30 mL/min/1.73 m2)-
    Diab. ketoacid.- Type 1 diab.- Hist. of serious hypersens. react. to this drug, sitagliptin, or metformin, such as anaphylaxis or angioedema.

    סרגל נגישות

    CLOSE